Terms: = Prostate cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Treatment
14 results:
1. [Impact of Oncological treatment on Perceived Stigmatization - A Register-Based Study].
Hornemann B; Haering C; Hentschel L; Rentsch A; Taubenheim S; Mehnert-Theuerkauf A; Esser P; Ernst J
Psychother Psychosom Med Psychol; 2023 Aug; 73(8):328-336. PubMed ID: 37054742
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
3. Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.
Oehrlein N; Streicher SA; Kuo HC; Chaurasia A; McFadden J; Nousome D; Chen Y; Stroup SP; Musser J; Brand T; Porter C; Rosner IL; Chesnut GT; Onofaro KC; Rebbeck TR; D'Amico A; Lu-Yao G; Cullen J
Cancer Med; 2022 Nov; 11(22):4354-4365. PubMed ID: 35638719
[TBL] [Abstract] [Full Text] [Related]
4. Gold Nanorods are Selective Cytotoxic Agents.
El Gendy M; Weinfeld M; Abdoon A
Anticancer Agents Med Chem; 2022; 22(5):991-998. PubMed ID: 34315395
[TBL] [Abstract] [Full Text] [Related]
5. Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
Ernst J; Mehnert A; Dietz A; Hornemann B; Esser P
BMC Cancer; 2017 Nov; 17(1):741. PubMed ID: 29121876
[TBL] [Abstract] [Full Text] [Related]
6. Metastatic prostate cancer in the modern era of PSA screening.
Fontenot PA; Nehra A; Parker W; Wyre H; Mirza M; Duchene DA; Holzbeierlein J; Thrasher JB; Van Veldhuizen P; Lee EK
Int Braz J Urol; 2017; 43(3):416-421. PubMed ID: 28338310
[TBL] [Abstract] [Full Text] [Related]
7. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
[TBL] [Abstract] [Full Text] [Related]
8. Screening for prostate cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
[TBL] [Abstract] [Full Text] [Related]
9. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007
[TBL] [Abstract] [Full Text] [Related]
10. MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer.
Marigliano C; Donati OF; Vargas HA; Akin O; Goldman DA; Eastham JA; Zelefsky MJ; Hricak H
Eur J Radiol; 2013 Dec; 82(12):e775-81. PubMed ID: 24119430
[TBL] [Abstract] [Full Text] [Related]
11. Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.
Tahir SA; Kurosaka S; Tanimoto R; Goltsov AA; Park S; Thompson TC
Cancer Biol Ther; 2013 Feb; 14(2):117-26. PubMed ID: 23114714
[TBL] [Abstract] [Full Text] [Related]
12. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
Bott SR; Arya M; Kirby RS; Williamson M
Prostate Cancer Prostatic Dis; 2005; 8(4):321-6. PubMed ID: 16276353
[TBL] [Abstract] [Full Text] [Related]
13. Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestation.
Mauri D; Pentheroudakis G; Tolis C; Chojnacka M; Pavlidis N
Urol Oncol; 2005; 23(5):318-22. PubMed ID: 16144664
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor.
Frković-Grazio S; Kraljić I; Trnski D; Tarle M
Anticancer Res; 1994; 14(5B):2151-6. PubMed ID: 7840515
[TBL] [Abstract] [Full Text] [Related]
